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Dear Sir,
Wale et al. present a comprehensive study of 99mTc-
methoxyisobutylisonitrile scintigraphy in cold thyroid nod-
ules (CTNs) [1]. They conclude that MIBI scintigraphy can
usefully exclude malignancy of nondiagnostic (Thy1) and
nonneoplastic (Thy2) lesions, but consider MIBI scintigraphy
as a second-line investigation in the management of CTNs
(see their Fig. 4) [1]. To expand this point, we suggest that
MIBI scintigraphy should be considered as a first-line inves-
tigation in the management of CTNs.
We assessed the clinical significance of 99mTc-MIBI scin-
tigraphy in the assessment of 104 patients with CTNs, in 14 of
whom the histological findings were malignant and in 90
benign [2]. When 99mTc-MIBI uptake was regarded as the
criterion of malignancy in 99mTc-MIBI scintigraphy, the accu-
racy using seven different methods was in the range
69.46 – 92.21 % [2]. There were six malignant cold nodules
based on histopathology which were considered as benign
nodules on fine-needle aspiration cytology (FNAC). All such
nodules showed some degrees of 99mTc-MIBI uptake [2]. The-
se findings are of particular interest considering the fact that our
previous study showed a sensitivity of FNAC of just 53.84 %
in the detection of malignancy of the thyroid as compared with
final histopathology in 198 thyroidectomized patients [3]. The
sensitivity in the current study was 66.66 % [2]. We also see a
number of cases of discrepancy between FNAC and 99mTc-
MIBI scintigraphy in our ongoing daily practice.
Therefore, based on these findings and previous evidence
[4] and the inadequate ability of FNAC to detect thyroid
malignancy [5], we believe that 99mTc-MIBI scintigraphy
may have a great impact on the management of CTNs, and
we recommend using this method in routine practice and
management of CTNs. On the other hand, there are different
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methods of 99mTc-MIBI scintigraphy acquisition (early, de-
layed or both; planar or SPECT) and interpretation (equal,
increased 99mTc-MIBI uptake or both) in the imaging of CTNs
with different results. However, we observed that when a
nodule with equal or increased 99mTc-MIBI uptake in delayed
views is considered a malignant lesion, the sensitivity is
100 % [2]. In addition, it should be noted that a reliable
judgement of 99mTc-MIBI uptake in CTNs less than 1 cm in
diameter cannot be made due to the limited resolution of
current gamma cameras.
Overall, we suggest a combination of FNAC and
MIBI scan as a routine diagnostic approach to CTNs.
The need for a pragmatic approach to the education and
training of medical practitioners and nuclear medicine
assistants and physicians to achieve a change in the manage-
ment of patients with CTNs is more important following this
evidence.
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